U.S. flag

An official website of the United States government

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 2

1.
Figure 1

Figure 1. From: Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study.

RBM3 expression in primary melanomas and metastases. Examples of malignant melanomas with (A) negative, (B) weak, (C) intermediate and (D) strong immunohistochemical RBM3 staining. RBM3 expression was strong in the majority of (E) primary tumours compared to (F) metastases.

Liv Jonsson, et al. J Transl Med. 2011;9:114-114.

CitationFull text

2.
Figure 2

Figure 2. From: Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study.

Prognostic value of RBM3 expression in primary melanoma. Tumours with high (strong intensity) RBM3 expression had a significantly improved (A) recurrence free survival and (B) overall survival compared to tumours with low RBM3 expression (negative to moderate intensity).

Liv Jonsson, et al. J Transl Med. 2011;9:114-114.

CitationFull text

Supplemental Content

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center